期刊文献+

岩白菜素Soluplus/TPGS混合胶束的制备、表征及体外释药研究 被引量:3

Preparation,characterization and drug release in vitro of bergenin Soluplus/TPGS mixed micelles
原文传递
导出
摘要 目的:制备岩白菜素Soluplus/TPGS混合胶束(bergenin mixed micelles,Ber-MM),评价其体外释药行为。方法:薄膜水化法制备Ber-MM。选择包封率和载药量为指标,Box-Behnken设计-效应面法优化Ber-MM处方工艺,并制备冻干粉。X-射线粉末衍射分析Ber-MM晶型,透射电镜观察Ber-MM微观形态,透析法考察Ber-MM在pH 1.2、pH 4.5和pH 6.8介质中的释药行为,并对释药模型进行拟合。结果:Ber-MM最佳处方为:Soluplus/TPGS比例为8.3∶1、载体与药物比例为8.8∶1、水化体积为20.5 mL。包封率、载药量、粒径及Zeta电位分别为(93.56±1.34)%、(9.50±0.18)%、(71.19±4.08)nm和-(0.98±0.16)mV。岩白菜素在Ber-MM中转变为无定形态,TEM结果显示Ber-MM外貌为类球形。Ber-MM体外释药具有缓释特征,在3种pH介质中均符合Weibull模型。结论:Ber-MM粒径小,药物控释效果明显,可为后续临床开发奠定基础。 OBJECTIVE To prepare bergenin Soluplus/TPGS mixed micelles(Ber-MM)and evaluate drug release behavior in vitro.METHODS Thin film hydration method was used to prepare Ber-MM.Envelopment efficiency and drug loading were used as evaluation indexes,Box-Behnken response surface design method was employed to optimize the formulation of Ber-MM,and its lyophilized powder was also prepared.X-ray powder diffraction(XRPD)was used to analyze the crystal form in Ber-MM.Transmission electron microscope(TEM)was employed to observe its microscopic appearance.Release behavior of Ber-MM in pH1.2,pH4.5 and pH6.8 media was studied by dialysis method,and the release model was also fitted.RESULTS The optimal formulation of Ber-MM was as follows:the ratio of Soluplus/TPGS was 8.3∶1,the ratio of carrier to drug was 8.8∶1,and the hydration volume was 20.5 mL.The envelopment efficiency,drug loading,particle size and Zeta potential was(93.56±1.34)%,(9.50±0.18)%,(71.19±4.08)nm and-(0.98±0.16)mV,respectively.XRPD results showed that bergenin was changed into an amorphous form in Ber-MM.Ber-MM was spherical in appearance observed by TEM.Drug release of Ber-MM in vitro had obvious sustained-release characteristics,and the release model was consistent with Weibull model in the three kinds of pH media.CONCLUSION The size of Ber-MM is small,and the drug controlled release effect is obvious,which lays the foundation for subsequent clinical development.
作者 尚慧杰 杨金枝 张付利 SHANG Huijie;YANG Jinzhi;ZHANG Fuli(Department of Pharmacy,Zhengzhou Shuqing Medical College,Henan Zhengzhou 450064,China;School of Pharmacy,Henan University,Henan Kaifeng 475001,China)
出处 《中国医院药学杂志》 CAS 北大核心 2023年第11期1248-1254,共7页 Chinese Journal of Hospital Pharmacy
关键词 岩白菜素 混合胶束 Box-Behnken设计-效应面法 冻干粉 bergenin mixed micelles Box-Behnken response surface design method lyophilized powder
  • 相关文献

参考文献11

二级参考文献125

  • 1彭永芳,熊杰,杨昌红.岩白菜素提取工艺的改进[J].昆明学院学报,1996,27(S1):46-49. 被引量:6
  • 2纪兰菊.西藏产两种岩白菜中岩白菜素的HPLC测定[J].西北植物学报,2005,25(2):397-399. 被引量:19
  • 3孙敏,师冰,徐榕雪.岩白菜素提取工艺制剂及质量标准研究综述[J].云南中医中药杂志,2005,26(5):56-58. 被引量:17
  • 4谢明,周梁,高召兵.紫杉醇PLGA微球制备及工艺优化[J].中国医院药学杂志,2006,26(8):925-928. 被引量:7
  • 5WANGG MABJ.Overview of the reserches on bergenin .安徽中医学院学报,2002,21(6):59-61.
  • 6WU L J. Chemistry of Natural Products(天然药物化学)[M].Beijing: People's Medical Publishing House, 2003: 69-70.
  • 7SUNDJ CUIYQ ZHOUXG etal.A study of the solid dispersion ofbergenin .中成药,1987,9(3):1-3.
  • 8GUANGJY SUNDJ WUGL etal.Study on the inelution compound of bergenin .中成药,1991,13(1):4-5.
  • 9Nazir N, Koul S, Qurishi MA, Taneja SC, Ahmad SF, Bani S. Immunomodulatory effect of bergenin and norbergenin against adjuvantinduced arthritis-a flow cytometric study. J Ethnopharmacol 2007; 112: 401-5.
  • 10Ye YP, Sun HX, Pan YJ. Bergenin monohydrate from the rhizomae of Astilbe chinensis. Acta Crystallogr C 2004; 60: 397-8.

共引文献75

同被引文献50

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部